China Blood Collection Needle Labeling Line Price Guide 2026

Understanding the Market for Blood Collection Needle Labeling and Boxing Lines in China

Medical device manufacturers searching for a blood collection needle labeling and boxing line in China are often confronted with a wide spread of quotations, feature sets, and delivery timelines. This is because the price of such equipment is not a fixed number—it is a direct reflection of production capacity requirements, compliance standards, and the degree of customization built into the line. Understanding these variables is essential before comparing supplier quotes or committing to a procurement decision.

Shengqi Packaging Machinery, founded in 2004 and headquartered across Shanghai (Jinshan) and Suqian, Jiangsu, operates in this space as a provider of high-end automated packaging equipment and industrial robots. The company’s positioning centers on solving industry pain points that are especially acute in medical device manufacturing: high labor dependency, inconsistent manual production quality, contamination risks in sterile environments, and low throughput. For blood collection needle labeling specifically, precision is the defining requirement, since even minor labeling inconsistencies can create compliance and traceability issues downstream.

What Drives Cost and Value in These Systems

Buyers evaluating a labeling and boxing line for blood collection needles should recognize that price is shaped by several interlocking factors rather than a single specification. These include:

• The level of automation integrated into the line, from basic labeling to full secondary packaging with robotics
• Cleanroom and sterility compliance requirements, since medical consumables often demand controlled environments
• The degree of non-standard customization needed to match existing workshop layouts and production speeds
• After-sales service scope, including installation, maintenance, and technical support

Shengqi’s product structure reflects this reality directly. Blood Collection Needle Labeling is positioned within the company’s Specialized Medical Assembly & Labeling category, described as an automated labeling solution for medical consumables that addresses the core target pain point of precision requirements in medical labeling. This is grouped alongside COC Syringe Assembly, reinforcing that the company treats this category as a high-compliance assembly and labeling segment rather than a generic packaging line.

Shengqi’s Approach to Automated Labeling and Boxing

Rather than offering a one-size-fits-all machine, Shengqi frames its equipment around an integrated service model that spans R&D, design, production, assembly, and after-sales support. This matters directly to pricing conversations, because the final quotation for a labeling and boxing line depends on how much of this end-to-end process a buyer requires. A company purchasing a standalone labeling module will face different cost considerations than one requesting a fully integrated line that connects labeling with secondary packaging and robotic handling.

This integrated capability is visible in Shengqi’s broader Secondary Packaging & Robotics category, which includes robotic carton unpacking, wang-shaped or cross sealing, and palletizing. While these functions are documented for other product lines such as general secondary packaging and RO membrane packaging, they illustrate the underlying engineering competency—independent R&D of industrial robots and vision-guided systems under the Zihoo Robot brand—that Shengqi applies across its medical assembly and labeling equipment as well.

Compliance and Quality Standards Behind the Price

For blood collection needles and other medical consumables, compliance is not optional, and it is a significant driver of equipment cost. Shengqi’s capability system is built around GMP compliance certification and Class 100 laminar flow protection standards, with platform compatibility extending to Class A cleanroom standards and sterile production environments. These are not marketing claims in isolation; they correspond to documented customer outcomes. For example, the company’s COC Syringe Assembly line for sterile pharmaceutical production was delivered as a fully automated line with Class 100 protection, demonstrating the same compliance framework that underpins the company’s approach to sensitive medical device packaging.

For a buyer evaluating price quotes, this means a lower-cost quotation that omits proper cleanroom compatibility or GMP-aligned data and operational standards may create hidden downstream costs in the form of compliance failures or rework. Shengqi’s technology platform, which combines PLC intelligent control with HMI integration, is designed specifically to meet these stringent regulatory data and operational standards, which is a relevant consideration when comparing the total cost of ownership rather than sticker price alone.

How Customization Impacts Investment

Because Shengqi’s service scope explicitly includes non-standard solution customization and workshop space optimization, pricing for a blood collection needle labeling and boxing line is typically shaped through a consultative process rather than a fixed catalog price. This is consistent with how the company approaches its full product matrix, which spans fourteen documented product and service lines, from liquid and powder filling to specialized medical assembly and integrated smart factory solutions.

The company’s documented customer cases provide a useful frame of reference for how customization translates into measurable outcomes elsewhere in its portfolio. In one automated screw sorting project using robotic vision sorting, labor was reduced from 35 people to 1. In an environmental protection industry project involving RO membrane packaging, the company reports that 8 to 10 staff positions were saved and efficiency was improved by 100 percent. These figures illustrate the scale of labor and efficiency impact that automation can deliver when properly customized to a specific production environment, which is directly relevant to how a buyer should evaluate the return on investment behind any labeling and boxing line quotation, including for blood collection needles.

Global Manufacturing Base and Delivery Capabilities

Shengqi operates manufacturing bases in Shanghai and Jiangsu, supported by a 15,000 square meter production facility and registered capital of RMB 10,000,000. Its business coverage extends globally across North America, South America, Southeast Asia, Australia, Europe, and Africa, with export operations spanning six continents. For international buyers specifically searching for pricing on a China-based blood collection needle labeling and boxing line, this global delivery capability is a relevant factor, since the company’s delivery model includes global delivery and installation for international markets, backed by an integrated service team for maintenance and technical support after deployment.

Shengqi has also been recognized as a High-Tech Enterprise and as one of Shanghai’s “Specialized, Refined, Unique, and Innovative” Enterprises, credentials that speak to the technical foundation supporting its equipment across categories, including medical assembly and labeling.

Making an Informed Decision

Because pricing for a blood collection needle labeling and boxing line depends on automation level, compliance requirements, and the extent of customization, buyers are better served by requesting a scoped consultation than by comparing headline figures alone. Shengqi Packaging Machinery’s structure—spanning proprietary robotics, GMP and Class 100 compliant systems, and an integrated service model from design through after-sales support—reflects the kind of comprehensive framework that determines final cost. Companies evaluating this category can review further details through the company’s official channels at sqpack88.com or sqpack.com to obtain a quotation aligned to their specific production requirements.